Neurologic Manifestations  >>  AZD2066  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD2066 / AstraZeneca
NCT00939094: AZD2066 Neuropathic Pain - Mechanical Hypersensitivity

Terminated
2a
87
US
AZD2066, Placebo
AstraZeneca, Quintiles, Inc.
Neuropathic Pain, Mechanical Hypersensitivity
11/10
11/10

Download Options